Concurrent Technologies PLC
20 September 2000
Concurrent Technologies Plc
Deferred Shares
Concurrent Technologies Plc, which designs, produces and markets
single board computers known as Multibus II, CompactPCI and VME,
announces that it has completed the purchase of its outstanding
deferred shares.
All the deferred shares in the Company totalling 25,697,600 have been
bought back by the Company for £256.98 and converted into ordinary
shares of 1p.
The Directors; Peter Crowther, held in the Peter Crowther Self
Invested Pension Plan, Michael Collins, held in the Michael Collins
Self Invested Pension Plan, Glen Fawcett and Jane Annear; have sold
their holdings of deferred shares to the Company.
20 September 2000
Enquiries:
Concurrent Technologies Plc Tel. No. 01206 752626
Glen Fawcett, Managing Director
College Hill Tel. No. 020 7457 2020
Michael Padley / Nicolas Nelson
Copies of this announcement will be available from the Company's
Registered Office: Cargil Management Services, 22 Melton St., London
NW1 2BW, for a period of 14 days from the date of the announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.